Skip to main content
. 2015 Dec 21;5(2):145–152. doi: 10.1002/cam4.561

Table 1.

Exonal mutations in all of 12 exons of TP53 gene in the different grades of TCC

Grade I of TCC (18 patients, 30%, normal patients: 5)
Mutations/exons 1 2 3 4 5 6 7 8 9 10 11 12
Deletion 4 Ps 1 P 2 Ps 2 Ps
Duplication 1 P 2 Ps 3 Ps
Grade II of TCC (22 patients, 37%, normal patients: 9)
Deletion 4 Ps 2 Ps 1 P 2 Ps 1 P 3 Ps
Duplication 2 Ps 1 P 4 Ps 1 P 2 Ps
Grade III of TCC (13 patients, 22%, normal patients: 7)
Deletion 1 P 1 P 1 P 1 P 1 P
Duplication 1 P 1 P 2 Ps
Grade IV of TCC (seven patients, 11%, normal patients: 3)
Deletion 2 Ps 1 P 1 P
Duplication 1 P 2 Ps 1 P
Total deletion 11 1 1 3 3 3 4 5
Total duplication 4 1 7 3 6 3

Some of patients had both deletion and duplication or had more than one mutation. TCC, transitional cell carcinoma; P, patient.